KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Inventory Average (2016 - 2025)

Regeneron Pharmaceuticals has reported Inventory Average over the past 12 years, most recently at $3.2 billion for Q4 2025.

  • Quarterly results put Inventory Average at $3.2 billion for Q4 2025, up 5.73% from a year ago — trailing twelve months through Dec 2025 was $3.2 billion (up 5.73% YoY), and the annual figure for FY2025 was $3.1 billion, up 10.94%.
  • Inventory Average for Q4 2025 was $3.2 billion at Regeneron Pharmaceuticals, roughly flat from $3.2 billion in the prior quarter.
  • Over the last five years, Inventory Average for REGN hit a ceiling of $3.2 billion in Q3 2025 and a floor of $2.0 billion in Q1 2022.
  • Median Inventory Average over the past 5 years was $2.5 billion (2023), compared with a mean of $2.6 billion.
  • Biggest five-year swings in Inventory Average: surged 40.91% in 2021 and later fell 3.39% in 2022.
  • Regeneron Pharmaceuticals' Inventory Average stood at $2.0 billion in 2021, then increased by 20.2% to $2.4 billion in 2022, then increased by 6.82% to $2.6 billion in 2023, then grew by 18.72% to $3.1 billion in 2024, then rose by 5.73% to $3.2 billion in 2025.
  • The last three reported values for Inventory Average were $3.2 billion (Q4 2025), $3.2 billion (Q3 2025), and $3.2 billion (Q2 2025) per Business Quant data.